Atomi Financial Group’s Novo Nordisk NVO Stock Holding History

Atomi Financial Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$667K	Sell	18,137 -12,200	-40%	-$578K	0.02%	593
2025 Q4	$1.54M	Buy	30,337 +2,294	+8%	+$117K	0.05%	282
2025 Q3	$1.56M	Sell	28,043 -10,687	-28%	-$626K	0.05%	251
2025 Q2	$2.67M	Buy	38,730 +8,560	+28%	+$582K	0.1%	148
2025 Q1	$2.09M	Sell	30,170 -1,976	-6%	-$163K	0.1%	159
2024 Q4	$2.77M	Buy	32,146 +1,473	+5%	+$159K	0.14%	117
2024 Q3	$3.65M	Sell	30,673 -2,203	-7%	-$294K	0.23%	87
2024 Q2	$4.69M	Buy	32,876 +4,937	+18%	+$654K	0.35%	61
2024 Q1	$3.59M	Buy	27,939 +3,170	+13%	+$377K	0.33%	67
2023 Q4	$2.56M	Buy	24,769 +16,802	+211%	+$1.66M	0.35%	59
2023 Q3	$725K	Buy	+7,967	New	+$702K	0.24%	107

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Atomi Financial Group's NVO Position: Q1 2026 in Review

Atomi Financial Group reduced its Novo Nordisk (NVO) stake by 40% in Q1 2026, selling an estimated $578K and leaving 18,137 shares worth $667K. The position accounts for 0.02% of the portfolio, ranked #593.

Atomi Financial Group first reported a position in NVO in Q3 2023 and has held it in 11 quarters since. The position peaked at $4.69M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Atomi Financial Group held 18,137 shares of Novo Nordisk worth $667K as of Q1 2026.
Atomi Financial Group sold 12,200 Novo Nordisk shares in Q1 2026, an estimated $578K.
Novo Nordisk made up 0.02% of Atomi Financial Group's portfolio in Q1 2026, its #593 holding.
Atomi Financial Group first reported a position in Novo Nordisk in Q3 2023 and has held it in 11 quarters since.
Atomi Financial Group's Novo Nordisk position peaked at $4.69M in Q2 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.